Comparison of the Efficacy of an Integrative-kinesiological to a Cognitive-behavioural Intervention
IKSIT
Psychoneuroendocrinological Efficacy Study of an Integrative-kinesiological to a Cognitive-behavioural Intervention With Healthy Individuals
1 other identifier
interventional
64
1 country
1
Brief Summary
Stress is a common problem with significant consequences for health. It can be a trigger for somatic diseases as well as psychological disorders and leads through missed working days and healthcare cost to a high economic loss. It is for health and economic reasons essential to develop and evaluate effective interventions that can inoculate against stress and build inner strength. A cognitive-behavioural training for groups that is well evaluated and has shown to be effective is the Stress-Inoculation-Training by Meichenbaum. As the public utilization of methods of the complementary and alternative medicine is increasing a rigorous evaluation is needed. Integrative Kinesiology is a popular method that has been said to be effective against stress and its symptoms. The investigators propose a randomized controlled evaluation and comparison of the interventions to each other and to a waiting-list control group. Hypothesis: Healthy volunteers attending a two dayseminar will show significantly reduced psychobiological reactivity, decreased stress perception and less anxiety to a standardized psychosocial stress test compared to the waiting list group. A total of 64 healthy volunteers will be randomly assigned to one of the three groups. The efficacy of the interventions will be measured through the Trier Social Stress Test (TSST) to measure the psychobiological stress reactivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 healthy
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2011
CompletedFirst Posted
Study publicly available on registry
April 8, 2011
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedNovember 5, 2015
October 1, 2015
7 months
April 4, 2011
November 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area under curve with respect to increase of salivary cortisol titer
TSST evaluation day will take place between 2 weeks and one month on average after the treatments are finished. Trier Social Stress Tests procedure will last close to two hours. Samples are collected at: T + 02; +25; +38; +48; +58; + 1:08; +1:23; + 1.38
8x during TSST
Secondary Outcomes (4)
Salivary alpha amylase reactivity to the TSST
8x during TSST
Sense of Coherence
Baseline, post intervention and follow up
Perceived Stress
Baseline, post intervention and follow up
self efficacy expectancy
Baseline, post intervention and follow up
Study Arms (3)
Cognitive behavioural Intervention
EXPERIMENTALIntegrative Kinesiology Intervention
EXPERIMENTALWaiting-List control group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Ready to participate in randomly one of the three groups
- mentally and physically healthy
- Sufficient German-speaking abilities to participate in the training
You may not qualify if:
- previous experience with Integrative Kinesiology or cognitive-behavioural therapy
- previous experience with the Trier Social Stress Test
- daily alcohol consumption: \> two alcoholic drinks
- daily tobacco consumption: \> 5 cigarettes per day
- any kind of drug abuse
- pregnancy, after the second trimenon
- intake ofe hormonal compounds (birth control pill and hormon replacement therapy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Zurich
Zurich, Canton of Zurich, 8032, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Lars B. Sonderegger
University of Zurich
- STUDY CHAIR
Reinhard Saller, Prof.
University of Zurich
- STUDY CHAIR
Ulrike Ehlert, Prof.
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2011
First Posted
April 8, 2011
Study Start
December 1, 2013
Primary Completion
July 1, 2014
Study Completion
September 1, 2014
Last Updated
November 5, 2015
Record last verified: 2015-10